Evolent Health is acquiring IPG, a provider of musculoskeletal surgical solutions. Evolent Health will pay $375 million in cash and an additional $87 million based on IPG's future performance. The deal is scheduled to close in Q3 2022.

Evolent Health's GAAP loss for the 3 months of 2022 was $5.35 million, down 45.4% from $9.807 million in the prior year. Revenue increased 38.1% to $297.057 million from $215.071 million a year earlier.

Evolent Health's GAAP loss for 2021 was $37.601 million, down 8.8 times from $334.246 million in the previous year. Revenue fell 1.8% to $907.957 million from $924.639 million a year earlier.

Evolent Health's GAAP loss for 9M 2021 was $31.954m, down 10 times from $320.443m in the previous year. Revenues decreased 2.7% to $659.599m from $678.103m a year earlier.